Ernexa Therapeutics Inc.
ERNAW· Nasdaq
Released Nov 8, 2016, after the close
10-Q filed Nov 9, 2016, 40 days after period end · 0001493152-16-014680
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $5.44M | $6.08M | $6.01M | $5.53M |
| Net Income | -$573.00K | -$1.35M | -$1.32M | -$234.00K |
| EPS Diluted |
Ernexa Therapeutics Inc. · CIK 748592 · Engraved from SEC EDGAR
| -$0.31 |
| -$0.73 |
| -$0.01 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.